摘要
目的 探究督脉灸联合摩罗丹治疗胃脘痛的临床疗效。方法 选取2023年1月至2024年1月于上饶市中心医院治疗的90例胃脘痛患者,以随机数字表法分为两组,即对照组(n=45)、研究组(n=45),均接受常规对症处理,对照组予以摩罗丹治疗,研究组予以督脉灸联合摩罗丹治疗,治疗15 d。比较两组临床疗效,胃痛程度[视觉模拟评分(VAS)],症状程度(胃脘痛-脾胃病医生报告结局症状量化标准)、生存质量[生活质量评定问卷(GQOLI-74)]。结果 与对照组比,研究组总有效率更高,差异有统计学意义(P<0.05)。治疗后,两组VAS评分、症状程度评分均下降,且研究组低于对照组;两组GQOLI-74评分提高,且研究组高于对照组,差异有统计学意义(P<0.05)。结论 督脉灸联合摩罗丹治疗胃脘痛可提高疗效,减轻疼痛度及症状程度,提高生存质量。
Objective To investigate the clinical efficacy of the treatment of epigastric pain by combining dumai moxibustion with morodan.Methods Ninety patients with epigastric pain treated in Shangrao Central Hospital from January 2023 to January 2024 were selected and divided into two groups by randomized table method,the control group(n=45)and the research group(n=45),all of them received conventional symptomatic treatment,based on which the control group was treated with morodan,and the research group were treated with dumai moxibustion combined with morodan,all treated for 15 d.The clinical effects,the degree of gastric pain[visual analog score(VAS)],the degree of gastric pain[Visual Analog Score(VAS)],the degree of symptoms(Gastroparesis-Quantitative Standards for Physician-Reported Outcome Symptoms in Spleen and Stomach Diseases),and the quality of survival[Quality of Life Assessment Questionnaire(GQOLI-74)]of the two groups were compared.Results Compared with the control group,the total effective rate was higher in the research group,and there was a statistical difference(P<0.05);after treatment,the VAS score and symptom degree score decreased in both groups,and the research group was lower than the control group;the GQOLI-74 score increased in both groups,and the research group was higher than the control group,and there was a statistical difference(P<0.05).Conclusion The treatment of epigastric pain with dumai moxibustion combined with morodan can improve the efficacy,reduce the degree of pain and the degree of symptoms,and improve the quality of survival.
作者
张冬梅
付瑶
周赟
ZHANG Dongmei;FU Yao;ZHOU Yun(Shangrao Central Hospital,Shangrao Jiangxi 334000,China)
出处
《药品评价》
CAS
2024年第6期739-742,共4页
Drug Evaluation
基金
上饶市2023年度社会发展领域科技计划项目(2023CZDX74)。
关键词
胃脘痛
督脉灸
摩罗丹
症状程度
生存质量
Epigastric pain
Dumai moxibustion
Morodan
Severity of symptoms
Quality of life